Chi‐Sheng Wu

864 total citations
25 papers, 461 citations indexed

About

Chi‐Sheng Wu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Chi‐Sheng Wu has authored 25 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Chi‐Sheng Wu's work include Epigenetics and DNA Methylation (5 papers), Allergic Rhinitis and Sensitization (4 papers) and RNA modifications and cancer (4 papers). Chi‐Sheng Wu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Allergic Rhinitis and Sensitization (4 papers) and RNA modifications and cancer (4 papers). Chi‐Sheng Wu collaborates with scholars based in Taiwan, United States and United Kingdom. Chi‐Sheng Wu's co-authors include Yu‐Sun Chang, Yu‐Wei Leu, Lih‐Chyang Chen, Yen‐Jung Lu, Wei‐Ning Lin, Jia‐Feng Chang, Hsin‐Pai Li, Hao‐Ping Liu, Kwang‐Huei Lin and Kuan‐Der Lee and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Chi‐Sheng Wu

22 papers receiving 459 citations

Peers

Chi‐Sheng Wu
Comparison fields: 5 of 83
  • Molecular Biology 287
  • Cancer Research 103
  • Oncology 70
  • Genetics 61
  • Epidemiology 49
Replace Pavel Mazánek with:
Pavel Mazánek Czechia
Shilpa Rao United States
Julio Cordero Germany
John Biddlestone United Kingdom
Xiangsheng Yang China
Irati Romero‐Garmendia Spain
Chundi He China
Shanshan Shi China
Pavel Mazánek Czechia View profile →
Citations per field, relative to Chi‐Sheng Wu
Chi‐Sheng Wu · 1×
Citations per year, relative to Chi‐Sheng Wu
Chi‐Sheng Wu · 1×

Countries citing papers authored by Chi‐Sheng Wu

Since Specialization
Citations

This map shows the geographic impact of Chi‐Sheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Sheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Sheng Wu more than expected).

Fields of papers citing papers by Chi‐Sheng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Sheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Sheng Wu. The network helps show where Chi‐Sheng Wu may publish in the future.

Co-authorship network of co-authors of Chi‐Sheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Sheng Wu. A scholar is included among the top collaborators of Chi‐Sheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Sheng Wu. Chi‐Sheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 3
4 0
5 3
6 2
7 1
8 6
9 9
10 23
11 10
12 15
13 18
14 3
15 23
16 79
17 62
18 47
19 29
20 52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026